Showing 1 - 5 results of 5 for search 'Lorenzo Antonuzzo', query time: 0.01s Refine Results
  1. 1
    Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration

    Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration by Giuseppe Defazio, Federico Scolari, Sara Fancelli, Simone Polvani, Daniele Lavacchi, Lucia Picariello, Alessandro Tubita, Michaela Luconi, Lorenzo Antonuzzo, Lorenzo Antonuzzo, Andrea Galli, Serena Pillozzi

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors

    Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors by Martina Catalano, Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marta Gatta Michelet, Silvia Mancini, Clara Manneschi, Sonia Shabani, Brunella Napolitano, Serena Pillozzi, Lorenzo Antonuzzo, Giandomenico Roviello

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Robotic approach with neoadjuvant chemotherapy in adult Wilms’ tumor: A feasibility study report and a systematic review of the literature

    Robotic approach with neoadjuvant chemotherapy in adult Wilms’ tumor: A feasibility study report and a systematic review of the literature by Simone Sforza, Valeria Emma Palmieri, Maria Rosaria Raspollini, Giandomenico Roviello, Alberto Mantovani, Umberto Basso, Maria Carmen Affinita, Alberto D'Angelo, Lorenzo Antonuzzo, Marco Carini, Andrea Minervini, Lorenzo Masieri

    Published 2023-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial

    Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual... by Vincenzo Nasca, Francesca Bergamo, Luisa Foltran, Lorenzo Antonuzzo, Katia Bencardino, Emanuela Dell’Aquila, Salvatore Corallo, Andrea Spallanzani, Oronzo Brunetti, Daniele Spada, Stefano Tamberi, Chiara Alessandra Cella, Antonio Avallone, Lorenzo Fornaro, Samantha Di Donato, Antonia Strippoli, Alberto Puccini, Emiliano Tamburini, Federica Palermo, Federica Morano, Filippo Pietrantonio, Alessandra Raimondi

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol

    Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological mark... by Ivan Lolli, Daniele Santini, Rossana Berardi, Giuseppe Badalamenti, Toni Ibrahim, Alfredo Berruti, Alberto Bongiovanni, Chiara Liverani, Sara Pusceddu, Silvana Leo, Giovanni Di Meglio, Stefano Tamberi, Fabio Gelsomino, Francesca Pucci, Francesca Bergamo, Sergio Ricci, Flavia Foca, Stefano Severi, Mauro Cives, Davide Campana, Nicola Silvestris, Angela Buonadonna, Maria Pia Brizzi, Francesca Spada, Sara Cingarlini, Lorenzo Antonuzzo, Davide Pastorelli

    Published 2020-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: